Table I.
Distribution of study subjects with HB and their serum AFP levels.
| Case | Age (months)a | Gender | Diagnosis HB type | AFP (ng/ml)b | Viral hepatitis | Chip |
|---|---|---|---|---|---|---|
| 1 | 7 | Male | Mixed embryonal/fetal subtype | 68,490 | None | 1 |
| 2 | 23 | Male | Mixed embryonal/fetal subtype | >121,000 | None | 2 |
| 3 | 11 | Female | Mixed embryonal/fetal subtype | >121,000 | None | 3 |
| 4 | 10 | Female | Mixed embryonal/fetal subtype | >121,000 | None | – |
| 5 | 20 | Female | Mixed embryonal/fetal subtype | >121,000 | None | – |
| 6 | 7 | Male | Mixed embryonal/fetal subtype | >121,000 | None | – |
| 7 | 30 | Male | Epithelial type | >121,000 | None | – |
| 8 | 14 | Male | Epithelial type | >121,000 | None | – |
| 9 | 19 | Male | Epithelial type | >121,000 | None | – |
| 10 | 7 | Female | Epithelial type | >121,000 | None | – |
a
Age on the day that the serum sample was collected.
b
AFP normal range, ≤25 ng/ml. AFP, alpha-fetoprotein; HB, hepatoblastoma.